These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38001714)

  • 21. LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to protect β-catenin from degradation.
    Zhou M; Pan S; Qin T; Zhao C; Yin T; Gao Y; Liu Y; Zhang Z; Shi Y; Bai Y; Gong J; Guo X; Wang M; Qin R
    J Exp Clin Cancer Res; 2022 Sep; 41(1):288. PubMed ID: 36171592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic syndrome related gene signature predicts the prognosis of patients with pancreatic ductal carcinoma. A novel link between metabolic dysregulation and pancreatic ductal carcinoma.
    Cai W; Bao W; Chen S; Yang Y; Li Y
    Cancer Cell Int; 2021 Dec; 21(1):698. PubMed ID: 34930261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulated expression of IL‑28RA is involved in the pathogenesis of pancreatic ductal adenocarcinoma.
    Liu L; Qi Y; Huang D; Xu Y; Li M; Hong Z; Gu Y; Jia B; Luo X; Zhang S; Zhang S
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
    Song C; Chen T; He L; Ma N; Li JA; Rong YF; Fang Y; Liu M; Xie D; Lou W
    Cell Oncol (Dordr); 2020 Feb; 43(1):51-62. PubMed ID: 31520395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
    Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
    J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutathione S-Transferase pi-1 Knockdown Reduces Pancreatic Ductal Adenocarcinoma Growth by Activating Oxidative Stress Response Pathways.
    Singh RR; Mohammad J; Orr M; Reindl KM
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32526885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma.
    Cai Y; Li X; Shen P; Zhang D
    Biol Res; 2018 Jan; 51(1):1. PubMed ID: 29298720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression pattern and prognostic value of key regulators for N7-methylguanosine RNA modification in prostate cancer.
    Zhai Q; Hou Y; Ye Y; Dai S; Guo G; Yang Q; Pang G; Wei Q
    Acta Biochim Biophys Sin (Shanghai); 2023 Feb; 55(4):561-573. PubMed ID: 36810782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A genetic variant conferred high expression of CAV2 promotes pancreatic cancer progression and associates with poor prognosis.
    Zhu Y; Tian J; Peng X; Wang X; Yang N; Ying P; Wang H; Li B; Li Y; Zhang M; Cai Y; Lu Z; Niu S; Li Y; Zhong R; Chang J; Miao X
    Eur J Cancer; 2021 Jul; 151():94-105. PubMed ID: 33975060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. lncRNA
    Li N; Yang G; Luo L; Ling L; Wang X; Shi L; Lan J; Jia X; Zhang Q; Long Z; Liu J; Hu W; He Z; Liu H; Liu W; Zheng G
    Clin Cancer Res; 2020 Apr; 26(7):1736-1748. PubMed ID: 31831555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
    Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
    J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N7-Methylguanosine Regulatory Genes Profoundly Affect the Prognosis, Progression, and Antitumor Immune Response of Hepatocellular Carcinoma.
    Zhou K; Yang J; Li X; Xiong W; Zhang P; Zhang X
    Front Surg; 2022; 9():893977. PubMed ID: 35784919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway.
    Wu L; Liu Y; Guo C; Shao Y
    Cancer Cell Int; 2020; 20():296. PubMed ID: 32669972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VSIG2 promotes malignant progression of pancreatic ductal adenocarcinoma by enhancing LAMTOR2-mediated mTOR activation.
    Xu J; Quan G; Huang W; Jiang J
    Cell Commun Signal; 2023 Aug; 21(1):223. PubMed ID: 37626304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of GRIN2D as a novel therapeutic target in pancreatic ductal adenocarcinoma.
    Wang J; Wong CH; Zhu Y; Yao X; Ng KKC; Zhou C; To KF; Chen Y
    Biomark Res; 2023 Aug; 11(1):74. PubMed ID: 37553583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miRNA-193b-5p Suppresses Pancreatic Cancer Cell Proliferation, Invasion, Epithelial Mesenchymal Transition, and Tumor Growth by Inhibiting eEF2K.
    Gurbuz N; Kahraman N; Sonmez HE; Mokhlis HA; Kosar PA; Ozpolat B
    Anticancer Agents Med Chem; 2022; 22(14):2607-2618. PubMed ID: 35718922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma.
    Chianese U; Papulino C; Ali A; Ciardiello F; Cappabianca S; Altucci L; Carafa V; Benedetti R
    J Transl Med; 2023 Jan; 21(1):32. PubMed ID: 36650542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of
    Yang C; Wang X; Qiu C; Zheng Z; Lin K; Tu M; Zhang K; Jiang K; Gao W
    PeerJ; 2022; 9():e12736. PubMed ID: 35036176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. METTL3 suppresses pancreatic ductal adenocarcinoma progression through activating endogenous dsRNA-induced anti-tumor immunity.
    Zhu L; Li B; Li R; Hu L; Zhang Y; Zhang Z; Jiang S; Zhang X
    Cell Oncol (Dordr); 2023 Oct; 46(5):1529-1541. PubMed ID: 37178367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.